Centene Corporation (CNC) Revenue History
Annual and quarterly revenue from 2014 to 2025
Compound Annual Growth Rate (CAGR)
Loading revenue history...
Revenue Growth Metrics
Revenue Breakdown (FY 2024)
CNC's revenue distribution by segment and geography for fiscal year 2024
By Product/Segment
CNC Revenue Analysis (2014–2025)
As of March 1, 2026, Centene Corporation (CNC) generated trailing twelve-month (TTM) revenue of $194.78 billion, reflecting exceptional growth of +21.9% year-over-year. The most recent quarter (Q4 2025) recorded $49.73 billion in revenue, up 0.1% sequentially.
Looking at the longer-term picture, CNC's 5-year compound annual growth rate (CAGR) stands at +11.9%, indicating consistent double-digit revenue growth. The company achieved its highest annual revenue of $194.78 billion in 2025, representing a new all-time high.
Revenue diversification analysis shows CNC's business is primarily driven by Medicaid Segment (76%), Commercial Segment (21%), and Other Operating Segment (3%). With over half of revenue concentrated in Medicaid Segment, the company maintains significant focus in this area while developing other growth vectors.
When compared to Healthcare sector peers including MOH (+11.7% YoY), CNC has outperformed the peer group in terms of revenue growth. Compare CNC vs MOH →
Peer Comparison
Compare CNC's revenue metrics with industry peers
| Company | TTM Revenue | YoY Growth | 5Y CAGR | Op. Margin | Compare |
|---|---|---|---|---|---|
| CNCCurrent | $194.8B | +21.9% | +11.9% | -3.9% | |
| MOH | $45.4B | +11.7% | +18.5% | 1.7% |
Historical Revenue Data
| Year | Revenue | YoY % | Gross Profit | Gross Margin | Op. Income | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | $194.78B | +19.4% | $23.83B | 12.2% | $-7,618,375,000 | -3.9% |
| 2024 | $163.07B | +5.9% | $16.83B | 10.3% | $3.17B | 1.9% |
| 2023 | $154.00B | +6.5% | $17.32B | 11.2% | $2.93B | 1.9% |
| 2022 | $144.55B | +14.7% | $16.66B | 11.5% | $1.32B | 0.9% |
| 2021 | $125.98B | +13.4% | $14.20B | 11.3% | $1.78B | 1.4% |
| 2020 | $111.11B | +48.9% | $15.22B | 13.7% | $3.08B | 2.8% |
| 2019 | $74.64B | +24.2% | $8.84B | 11.8% | $1.78B | 2.4% |
| 2018 | $60.12B | +24.3% | $8.42B | 14.0% | $1.46B | 2.4% |
| 2017 | $48.38B | +19.1% | $5.80B | 12.0% | $1.20B | 2.5% |
| 2016 | $40.61B | +78.4% | $5.54B | 13.7% | $1.26B | 3.1% |
See CNC's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs CNC Undervalued?
See our Bear / Base / Bull DCF models and intrinsic value estimates.
View ValuationCompare CNC vs AGIO
See how CNC stacks up against sector leader Agios Pharmaceuticals, Inc..
Start ComparisonFrequently Asked Questions
Is CNC's revenue growth accelerating or slowing?
CNC revenue is accelerating at +21.9% year-over-year, exceeding the 5-year CAGR of +11.9%. TTM revenue reached $194.8B. Growth momentum has increased versus prior periods.
What is CNC's long-term revenue growth rate?
Centene Corporation's 5-year revenue CAGR of +11.9% reflects the sustained expansion pattern. Current YoY growth of +21.9% is above this long-term average.
How is CNC's revenue distributed by segment?
CNC reports revenue by product line and geographic region. Annual and quarterly breakdowns from 2014-2025 are available for download. Segment mix reveals concentration and diversification trends.